Pharmacopsychiatry 2004; 37(3): 134-138
DOI: 10.1055/s-2004-818993
Letter
© Georg Thieme Verlag KG Stuttgart · New York

Esophageal Dysfunction on Psychotropic Medication

A Case Report and Literature ReviewAlessia S. Maddalena1 , Mark Fox2 , Marc Hofmann1 , Christoph Hock1
  • 1Division of Psychiatry Research, Psychiatric University Hospital Zurich, Switzerland
  • 2Department of Gastroenterology, University Hospital Zurich, Switzerland
Weitere Informationen

Publikationsverlauf

Received: 13.11.2002 Revised: 8.1.2003

Accepted: 2.4.2003

Publikationsdatum:
12. Mai 2004 (online)

We report the association of long-term clozapine and clomipramine therapy with severe esophageal dilation and hypomotility in a patient with chronic schizophrenia leading to life threatening aspiration pneumonia. Severe aspiration pneumonia manifested suddenly and required intubation and intensive care. Gross impairment of swallowing function with esophageal dilation and hypomotility was detected on videofluoroscopy and manometry. The patient recovered well following a reduction in the dose of clozapine and the withdrawal of clomipramine. The restoration of esophageal function was documented by manometry. The reported side effects and possible pharmacological actions of clozapine, an atypical neuroleptic, and clomipramine, a tricyclic antidepressant, on esophageal motility are discussed.

References

  • 1 Baeyens R, van de Velde E, De Schepper A, Wollaert F, Reyntjens A. Effects of intravenous and oral domperidone on the motor function of the stomach and small intestine.  Postgrad Med J. 1979;  55 (Suppl 1) 19-23
  • 2 Bashford G, Bradd P. Drug-induced Parkinsonism associated with dysphagia and aspiration: a brief report.  J Geriatr Psychiatry Neurol. 1996;  9 133-135
  • 3 Brogden R N, Carmine A A, Heel R C, Speight T M, Avery G S. Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic.  Drugs. 1982;  24 360-400
  • 4 Bulling M. Drug-induced dysphagia.  Aust N Z J Med. 1999;  29 748
  • 5 Gregory R P, Smith P T, Rudge P. Tardive dyskinesia presenting as severe dysphagia.  J Neurol Neurosurg Psychiatry. 1992;  55 1203-1204
  • 6 Hinkes R, Quesada T V, Currier M B, Gonzalez-Blanco M. Aspiration pneumonia possibly secondary to clozapine-induced sialorrhea.  J Clin Psychopharmacol. 1996;  16 462-463
  • 7 Horiguchi J, Shingu T, Hayashi T. et al . Antipsychotic-induced life-threatening ‘esophageal dyskinesia’.  Int Clin Psychopharmacol. 1999;  14 123-127
  • 8 Hughes T A, Shone G, Lindsay G, Wiles C M. Severe dysphagia associated with major tranquillizer treatment.  Postgrad Med J. 1994;  70 581-583
  • 9 Kahrilas P J, Dodds W J, Hogan W J, Kern M, Arndorfer R C, Reece A. Esophageal peristaltic dysfunction in peptic esophagitis.  Gastroenterology. 1986;  91 897-904
  • 10 Laker M K, Cookson J C. Reflux oesophagitis and clozapine.  Int Clin Psychopharmacol. 1997;  12 37-39
  • 11 Leopold N A. Dysphagia in drug-induced Parkinsonism: a case report.  Dysphagia. 1996;  11 151-153
  • 12 Leopold N A, Kagel M C. Pharyngo-esophageal dysphagia in Parkinson’s disease.  Dysphagia. 1997;  12 11 - 18; discussion 19 -18; discussion 19 - 20
  • 13 Levy P, Feydy P. Improvement of dysphagia with motor disorders after stopping neuroleptic treatment.  Gastroenterol Clin Biol. 1997;  21 894-895
  • 14 McCarthy R H, Terkelsen K G. Esophageal dysfunction in two patients after clozapine treatment.  J Clin Psychopharmacol. 1994;  14 281-283
  • 15 Missale G, Missale C, Sigala S, Cestari R, Memo M, Lojacono L, Spano P. Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus.  Life Sci. 1990;  47 447-455
  • 16 Moss H B, Green A. Neuroleptic-associated dysphagia confirmed by esophageal manometry.  Am J Psychiatry. 1982;  139 515-516
  • 17 Pearlman C. Clozapine, nocturnal sialorrhea, and choking.  J Clin Psychopharmacol. 1994;  14 283
  • 18 Quigley E M. Gastric and small intestinal motility in health and disease.  Gastroenterol Clin North Am. 1996;  25 113-145
  • 19 Shamash J, Miall L, Williams F, Creamer D, Robinson S, Johnston D G. Dysphagia in the neuroleptic malignant syndrome.  Br J Psychiatry. 1994;  164 849-850
  • 20 Sliwa J A, Lis S. Drug-induced dysphagia.  Arch Phys Med Rehabil. 1993;  74 445-447
  • 21 Sokoloff L G, Pavlakovic R. Neuroleptic-induced dysphagia.  Dysphagia. 1997;  12 177-179
  • 22 Stewart J T. Reversible dysphagia associated with neuroleptic treatment.  J Am Geriatr Soc. 2001;  49 1260-1261
  • 23 Takahashi T, Kurosawa S, Wiley J W, Owyang C. Mechanism for the gastrokinetic action of domperidone. In vitro studies in guinea pigs.  Gastroenterology. 1991;  101 703-710

Christoph Hock, M.D.

Division of Psychiatry Research

Psychiatric University Hospital Zurich

Lenggstrasse 31

8029 Zurich

Switzerland

Telefon: +41-1-384-2271

Fax: +41-1-384-2275

eMail: chock@ bli.unizh.ch